Home » Analyst Articles – US

Image for Crescent Energy’s (CRGY) “Accumulate” Rating Reaffirmed at Johnson Rice

Crescent Energy’s (CRGY) “Accumulate” Rating Reaffirmed at Johnson Rice

Johnson Rice reissued their accumulate rating on shares of Crescent Energy (NYSE:CRGY – Free Report) in a research report sent to investors on Wednesday, Marketbeat Ratings reports. The brokerage currently has a $19.00 target... More of this article »
Image for Brookfield Asset Management (NYSE:BAM) Price Target Cut to $56.00 by Analysts at Scotiabank

Brookfield Asset Management (NYSE:BAM) Price Target Cut to $56.00 by Analysts at Scotiabank

Brookfield Asset Management (NYSE:BAM – Free Report) (TSE:BAM.A) had its price target cut by Scotiabank from $64.00 to $56.00 in a research report report published on Wednesday, MarketBeat.com reports. They currently have an... More of this article »
Image for Enterprise Products Partners (NYSE:EPD) Upgraded to Overweight at Wells Fargo & Company

Enterprise Products Partners (NYSE:EPD) Upgraded to Overweight at Wells Fargo & Company

Wells Fargo & Company upgraded shares of Enterprise Products Partners (NYSE:EPD – Free Report) from an equal weight rating to an overweight rating in a research report report published on Wednesday morning, Marketbeat reports.... More of this article »
Image for Traeger (NYSE:COOK) Price Target Cut to $75.00 by Analysts at Canaccord Genuity Group

Traeger (NYSE:COOK) Price Target Cut to $75.00 by Analysts at Canaccord Genuity Group

Traeger (NYSE:COOK – Free Report) had its price objective cut by Canaccord Genuity Group from $100.00 to $75.00 in a report released on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock. COOK has... More of this article »
Image for Carpenter Technology (NYSE:CRS) Coverage Initiated by Analysts at KeyCorp

Carpenter Technology (NYSE:CRS) Coverage Initiated by Analysts at KeyCorp

KeyCorp began coverage on shares of Carpenter Technology (NYSE:CRS – Free Report) in a research note released on Wednesday morning. The firm issued an overweight rating and a $380.00 price objective on the basic materials company’s... More of this article »
Image for Amylyx Pharmaceuticals (NASDAQ:AMLX) Given “Buy” Rating at HC Wainwright

Amylyx Pharmaceuticals (NASDAQ:AMLX) Given “Buy” Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) in a report issued on Wednesday morning,Benzinga reports. HC Wainwright currently has a $34.00 price target on the stock. Several... More of this article »
Image for Tigress Financial Issues Positive Forecast for Amazon.com (NASDAQ:AMZN) Stock Price

Tigress Financial Issues Positive Forecast for Amazon.com (NASDAQ:AMZN) Stock Price

Amazon.com (NASDAQ:AMZN) had its price target upped by Tigress Financial from $305.00 to $315.00 in a research note released on Wednesday morning,Benzinga reports. Tigress Financial currently has a buy rating on the e-commerce giant’s... More of this article »
Image for Amazon.com (NASDAQ:AMZN) Given New $280.00 Price Target at JPMorgan Chase & Co.

Amazon.com (NASDAQ:AMZN) Given New $280.00 Price Target at JPMorgan Chase & Co.

Amazon.com (NASDAQ:AMZN) had its price objective increased by JPMorgan Chase & Co. from $265.00 to $280.00 in a report released on Wednesday morning, Marketbeat Ratings reports. They currently have an overweight rating on the... More of this article »
Image for Achieve Life Sciences’ (ACHV) “Buy” Rating Reaffirmed at HC Wainwright

Achieve Life Sciences’ (ACHV) “Buy” Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Achieve Life Sciences (NASDAQ:ACHV – Free Report) in a research report released on Wednesday,Benzinga reports. They currently have a $12.00 price target on the biopharmaceutical... More of this article »
Image for Acuity (NYSE:AYI) Price Target Cut to $320.00 by Analysts at Robert W. Baird

Acuity (NYSE:AYI) Price Target Cut to $320.00 by Analysts at Robert W. Baird

Acuity (NYSE:AYI – Free Report) had its price objective cut by Robert W. Baird from $375.00 to $320.00 in a report issued on Wednesday morning,Benzinga reports. They currently have a neutral rating on the electronics maker’s... More of this article »
Image for Addus HomeCare (NASDAQ:ADUS) Given New $102.00 Price Target at Barclays

Addus HomeCare (NASDAQ:ADUS) Given New $102.00 Price Target at Barclays

Addus HomeCare (NASDAQ:ADUS – Free Report) had its price target cut by Barclays from $112.00 to $102.00 in a report issued on Wednesday,Benzinga reports. They currently have an underweight rating on the stock. A number of other... More of this article »
Image for APA (NASDAQ:APA) Given New $45.00 Price Target at Raymond James Financial

APA (NASDAQ:APA) Given New $45.00 Price Target at Raymond James Financial

APA (NASDAQ:APA – Free Report) had its price target hoisted by Raymond James Financial from $31.00 to $45.00 in a research note issued to investors on Wednesday,MarketScreener reports. The brokerage currently has an outperform... More of this article »
Image for Diageo (NYSE:DEO) Upgraded by BNP Paribas Exane to Neutral Rating

Diageo (NYSE:DEO) Upgraded by BNP Paribas Exane to Neutral Rating

BNP Paribas Exane upgraded shares of Diageo (NYSE:DEO – Free Report) from an underperform rating to a neutral rating in a research report released on Wednesday morning, Marketbeat reports. Several other equities analysts have... More of this article »
Image for Coeur Mining (NYSE:CDE) Now Covered by BMO Capital Markets

Coeur Mining (NYSE:CDE) Now Covered by BMO Capital Markets

BMO Capital Markets began coverage on shares of Coeur Mining (NYSE:CDE – Free Report) in a report published on Wednesday morning. The brokerage issued an outperform rating and a $27.00 price target on the basic materials company’s... More of this article »
Image for Alexandria Real Estate Equities’ (ARE) “Market Perform” Rating Reaffirmed at BMO Capital Markets

Alexandria Real Estate Equities’ (ARE) “Market Perform” Rating Reaffirmed at BMO Capital Markets

BMO Capital Markets restated their market perform rating on shares of Alexandria Real Estate Equities (NYSE:ARE – Free Report) in a report released on Wednesday morning, Marketbeat Ratings reports. They currently have a $52.00... More of this article »
Image for CVR Energy (NYSE:CVI) Upgraded to Market Perform at Raymond James Financial

CVR Energy (NYSE:CVI) Upgraded to Market Perform at Raymond James Financial

Raymond James Financial upgraded shares of CVR Energy (NYSE:CVI – Free Report) from an underperform rating to a market perform rating in a report issued on Wednesday, MarketBeat reports. CVI has been the subject of several other... More of this article »
Image for Alpha Modus (NASDAQ:AMOD) Now Covered by Analysts at Maxim Group

Alpha Modus (NASDAQ:AMOD) Now Covered by Analysts at Maxim Group

Maxim Group began coverage on shares of Alpha Modus (NASDAQ:AMOD – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. The brokerage issued a buy rating and a $1.50 target price on the stock. Several... More of this article »
Image for Brookfield (NYSE:BN) Price Target Lowered to $48.50 at Scotiabank

Brookfield (NYSE:BN) Price Target Lowered to $48.50 at Scotiabank

Brookfield (NYSE:BN – Free Report) had its price objective reduced by Scotiabank from $52.00 to $48.50 in a research note issued to investors on Wednesday morning, MarketBeat Ratings reports. They currently have a sector outperform... More of this article »
Image for Howmet Aerospace (NYSE:HWM) Now Covered by Analysts at KeyCorp

Howmet Aerospace (NYSE:HWM) Now Covered by Analysts at KeyCorp

KeyCorp initiated coverage on shares of Howmet Aerospace (NYSE:HWM – Free Report) in a report released on Wednesday morning. The firm issued a sector weight rating on the stock. HWM has been the subject of a number of other reports.... More of this article »
Image for Figma (NYSE:FIG) Coverage Initiated by Analysts at Oppenheimer

Figma (NYSE:FIG) Coverage Initiated by Analysts at Oppenheimer

Oppenheimer assumed coverage on shares of Figma (NYSE:FIG – Free Report) in a report published on Wednesday morning, MarketBeat reports. The brokerage issued a market perform rating on the stock. A number of other analysts have... More of this article »
Image for Cantor Fitzgerald Issues Positive Forecast for Centuri (NYSE:CTRI) Stock Price

Cantor Fitzgerald Issues Positive Forecast for Centuri (NYSE:CTRI) Stock Price

Centuri (NYSE:CTRI – Free Report) had its target price raised by Cantor Fitzgerald from $35.25 to $37.40 in a report released on Wednesday,Benzinga reports. They currently have an overweight rating on the stock. Several other... More of this article »
Image for BorgWarner (NYSE:BWA) Rating Increased to Outperform at Wolfe Research

BorgWarner (NYSE:BWA) Rating Increased to Outperform at Wolfe Research

Wolfe Research upgraded shares of BorgWarner (NYSE:BWA – Free Report) from a peer perform rating to an outperform rating in a research note published on Wednesday morning, Marketbeat.com reports. The firm currently has $68.00... More of this article »
Image for Progressive (NYSE:PGR) Given New $295.00 Price Target at Bank of America

Progressive (NYSE:PGR) Given New $295.00 Price Target at Bank of America

Progressive (NYSE:PGR – Free Report) had its price target decreased by Bank of America from $305.00 to $295.00 in a research report report published on Wednesday,Benzinga reports. Bank of America currently has a buy rating on... More of this article »
Image for Vertiv (NYSE:VRT) Now Covered by Analysts at HSBC

Vertiv (NYSE:VRT) Now Covered by Analysts at HSBC

HSBC assumed coverage on shares of Vertiv (NYSE:VRT – Free Report) in a research report report published on Wednesday morning, MarketBeat reports. The brokerage issued a buy rating and a $325.00 target price on the stock. A number... More of this article »
Image for Rocket Companies (NYSE:RKT) Now Covered by Analysts at Citizens Jmp

Rocket Companies (NYSE:RKT) Now Covered by Analysts at Citizens Jmp

Citizens Jmp started coverage on shares of Rocket Companies (NYSE:RKT – Free Report) in a research note issued to investors on Wednesday morning, MarketBeat Ratings reports. The brokerage issued a market perform rating on the... More of this article »
Image for TELA Bio (NASDAQ:TELA) Given New $2.00 Price Target at Lake Street Capital

TELA Bio (NASDAQ:TELA) Given New $2.00 Price Target at Lake Street Capital

TELA Bio (NASDAQ:TELA – Free Report) had its price objective lowered by Lake Street Capital from $3.00 to $2.00 in a research note released on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the... More of this article »
Image for Core & Main (NYSE:CNM) Price Target Cut to $62.00 by Analysts at Deutsche Bank Aktiengesellschaft

Core & Main (NYSE:CNM) Price Target Cut to $62.00 by Analysts at Deutsche Bank Aktiengesellschaft

Core & Main (NYSE:CNM – Free Report) had its price target cut by Deutsche Bank Aktiengesellschaft from $65.00 to $62.00 in a research report report published on Wednesday,Benzinga reports. They currently have a buy rating... More of this article »
Image for Delek US (NYSE:DK) Price Target Raised to $54.00 at Raymond James Financial

Delek US (NYSE:DK) Price Target Raised to $54.00 at Raymond James Financial

Delek US (NYSE:DK – Free Report) had its price objective lifted by Raymond James Financial from $47.00 to $54.00 in a research report sent to investors on Wednesday,Benzinga reports. Raymond James Financial currently has an outperform... More of this article »
Image for Green Plains (NASDAQ:GPRE) Given New $15.00 Price Target at BMO Capital Markets

Green Plains (NASDAQ:GPRE) Given New $15.00 Price Target at BMO Capital Markets

Green Plains (NASDAQ:GPRE – Free Report) had its price target boosted by BMO Capital Markets from $14.00 to $15.00 in a research report released on Wednesday,Benzinga reports. BMO Capital Markets currently has a market perform... More of this article »
Image for Compass Pathways (NASDAQ:CMPS) Price Target Cut to $16.00 by Analysts at Morgan Stanley

Compass Pathways (NASDAQ:CMPS) Price Target Cut to $16.00 by Analysts at Morgan Stanley

Compass Pathways (NASDAQ:CMPS – Free Report) had its price target decreased by Morgan Stanley from $18.00 to $16.00 in a research report report published on Wednesday,Benzinga reports. Morgan Stanley currently has an overweight... More of this article »
Image for Lake Street Capital Issues Positive Forecast for Paysign (NASDAQ:PAYS) Stock Price

Lake Street Capital Issues Positive Forecast for Paysign (NASDAQ:PAYS) Stock Price

Paysign (NASDAQ:PAYS – Free Report) had its price objective boosted by Lake Street Capital from $10.00 to $11.00 in a research note issued to investors on Wednesday morning,Benzinga reports. Lake Street Capital currently has... More of this article »
Image for Sutro Biopharma (NASDAQ:STRO) Given New $55.00 Price Target at Deutsche Bank Aktiengesellschaft

Sutro Biopharma (NASDAQ:STRO) Given New $55.00 Price Target at Deutsche Bank Aktiengesellschaft

Sutro Biopharma (NASDAQ:STRO – Free Report) had its price target hoisted by Deutsche Bank Aktiengesellschaft from $51.00 to $55.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage currently... More of this article »
Image for Cal-Maine Foods (NASDAQ:CALM) Price Target Lowered to $80.00 at BMO Capital Markets

Cal-Maine Foods (NASDAQ:CALM) Price Target Lowered to $80.00 at BMO Capital Markets

Cal-Maine Foods (NASDAQ:CALM – Free Report) had its price objective cut by BMO Capital Markets from $85.00 to $80.00 in a report published on Wednesday morning,Benzinga reports. They currently have a market perform rating on... More of this article »
Image for Kodiak AI’s (KDK) “Buy” Rating Reaffirmed at Chardan Capital

Kodiak AI’s (KDK) “Buy” Rating Reaffirmed at Chardan Capital

Chardan Capital reaffirmed their buy rating on shares of Kodiak AI (NASDAQ:KDK – Free Report) in a research report released on Wednesday,Benzinga reports. The brokerage currently has a $22.00 price objective on the stock. A... More of this article »
Image for KB Home (NYSE:KBH) Price Target Lowered to $63.00 at UBS Group

KB Home (NYSE:KBH) Price Target Lowered to $63.00 at UBS Group

KB Home (NYSE:KBH – Free Report) had its price target lowered by UBS Group from $71.00 to $63.00 in a research report released on Wednesday,Benzinga reports. The firm currently has a buy rating on the construction company’s... More of this article »
Image for Raymond James Financial Issues Positive Forecast for HF Sinclair (NYSE:DINO) Stock Price

Raymond James Financial Issues Positive Forecast for HF Sinclair (NYSE:DINO) Stock Price

HF Sinclair (NYSE:DINO – Free Report) had its price target lifted by Raymond James Financial from $66.00 to $75.00 in a report published on Wednesday morning,Benzinga reports. They currently have a strong-buy rating on the stock. Several... More of this article »
Image for Incyte (NASDAQ:INCY) Price Target Cut to $94.00 by Analysts at UBS Group

Incyte (NASDAQ:INCY) Price Target Cut to $94.00 by Analysts at UBS Group

Incyte (NASDAQ:INCY – Free Report) had its target price cut by UBS Group from $104.00 to $94.00 in a research note released on Wednesday morning,Benzinga reports. They currently have a neutral rating on the biopharmaceutical... More of this article »
Image for Corcept Therapeutics (NASDAQ:CORT) Price Target Cut to $60.00 by Analysts at HC Wainwright

Corcept Therapeutics (NASDAQ:CORT) Price Target Cut to $60.00 by Analysts at HC Wainwright

Corcept Therapeutics (NASDAQ:CORT – Free Report) had its price objective decreased by HC Wainwright from $67.00 to $60.00 in a report published on Wednesday morning,Benzinga reports. HC Wainwright currently has a buy rating on... More of this article »
Image for Flutter Entertainment (NYSE:FLUT) Price Target Cut to $160.00 by Analysts at UBS Group

Flutter Entertainment (NYSE:FLUT) Price Target Cut to $160.00 by Analysts at UBS Group

Flutter Entertainment (NYSE:FLUT – Free Report) had its target price reduced by UBS Group from $300.00 to $160.00 in a research report report published on Wednesday,Benzinga reports. UBS Group currently has a buy rating on the... More of this article »
Image for Morgan Stanley Issues Positive Forecast for Smithfield Foods (NASDAQ:SFD) Stock Price

Morgan Stanley Issues Positive Forecast for Smithfield Foods (NASDAQ:SFD) Stock Price

Smithfield Foods (NASDAQ:SFD – Free Report) had its price target hoisted by Morgan Stanley from $29.00 to $31.00 in a research note released on Wednesday,Benzinga reports. The firm currently has an overweight rating on the stock. Several... More of this article »
Image for MaxCyte (NASDAQ:MXCT) Given New $5.00 Price Target at Craig Hallum

MaxCyte (NASDAQ:MXCT) Given New $5.00 Price Target at Craig Hallum

MaxCyte (NASDAQ:MXCT – Free Report) had its price objective decreased by Craig Hallum from $7.00 to $5.00 in a research report sent to investors on Wednesday morning,Benzinga reports. Craig Hallum currently has a buy rating on... More of this article »
Image for Sportradar Group (NASDAQ:SRAD) Price Target Lowered to $24.00 at Morgan Stanley

Sportradar Group (NASDAQ:SRAD) Price Target Lowered to $24.00 at Morgan Stanley

Sportradar Group (NASDAQ:SRAD – Free Report) had its price objective trimmed by Morgan Stanley from $26.00 to $24.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The firm currently has an equal... More of this article »
Image for KB Home (NYSE:KBH) Price Target Cut to $56.00 by Analysts at The Goldman Sachs Group

KB Home (NYSE:KBH) Price Target Cut to $56.00 by Analysts at The Goldman Sachs Group

KB Home (NYSE:KBH – Free Report) had its price objective trimmed by The Goldman Sachs Group from $65.00 to $56.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a neutral rating... More of this article »
Image for Concentrix (NASDAQ:CNXC) Price Target Lowered to $38.00 at Barrington Research

Concentrix (NASDAQ:CNXC) Price Target Lowered to $38.00 at Barrington Research

Concentrix (NASDAQ:CNXC – Free Report) had its price target trimmed by Barrington Research from $62.00 to $38.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the... More of this article »
Image for American Financial Group (NYSE:AFG) Given New $140.00 Price Target at Keefe, Bruyette & Woods

American Financial Group (NYSE:AFG) Given New $140.00 Price Target at Keefe, Bruyette & Woods

American Financial Group (NYSE:AFG – Free Report) had its price target hoisted by Keefe, Bruyette & Woods from $134.00 to $140.00 in a research note issued to investors on Wednesday morning,Benzinga reports. Keefe, Bruyette... More of this article »
Image for Maze Therapeutics (NASDAQ:MAZE) Given New $110.00 Price Target at HC Wainwright

Maze Therapeutics (NASDAQ:MAZE) Given New $110.00 Price Target at HC Wainwright

Maze Therapeutics (NASDAQ:MAZE – Free Report) had its price objective boosted by HC Wainwright from $60.00 to $110.00 in a research note released on Wednesday morning,Benzinga reports. The firm currently has a buy rating on the... More of this article »
Image for Travere Therapeutics (NASDAQ:TVTX) Given New $41.00 Price Target at JPMorgan Chase & Co.

Travere Therapeutics (NASDAQ:TVTX) Given New $41.00 Price Target at JPMorgan Chase & Co.

Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target reduced by JPMorgan Chase & Co. from $44.00 to $41.00 in a report issued on Wednesday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight... More of this article »
Image for Franklin Covey (NYSE:FC) Receives Outperform Rating from Barrington Research

Franklin Covey (NYSE:FC) Receives Outperform Rating from Barrington Research

Barrington Research reiterated their outperform rating on shares of Franklin Covey (NYSE:FC – Free Report) in a research note published on Wednesday morning,Benzinga reports. They currently have a $25.00 target price on the... More of this article »
Image for Mizuho Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price

Mizuho Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price

Insmed (NASDAQ:INSM – Free Report) had its price target hoisted by Mizuho from $204.00 to $206.00 in a research note published on Wednesday,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s... More of this article »
Image for Maze Therapeutics (NASDAQ:MAZE) Receives Buy Rating from BTIG Research

Maze Therapeutics (NASDAQ:MAZE) Receives Buy Rating from BTIG Research

BTIG Research reiterated their buy rating on shares of Maze Therapeutics (NASDAQ:MAZE – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $46.00 price target on... More of this article »